EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Por:
Chieffo, A, Stefanini, GG, Price, S, Barbato, E, Tarantini, G, Karam, N, Moreno, R, Buchanan, GL, Gilard, M, Halvorsen, S, Huber, K, James, S, Neumann, FJ, Mollmann, H, Roffi, M, Tavazzi, G, Ferre, JM, Windecker, S, Dudek, D and Baumbach, A
Publicada:
14 may 2020
Resumen:
The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients and healthcare workers. The number of patients requiring hospital admission and intensive care may overwhelm health systems and negatively affect standard care for patients presenting with conditions needing emergency interventions. This position statements aims to assist cardiologists in the invasive management of acute coronary syndrome (ACS) patients in the context of the COVID-19 pandemic. To that end, we assembled a panel of interventional cardiologists and acute cardiac care specialists appointed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and from the Acute Cardiovascular Care Association (ACVC) and included the experience from the first and worst affected areas in Europe. Modified diagnostic and treatment algorithms are proposed to adapt evidence-based protocols for this unprecedented challenge. Various clinical scenarios, as well as management algorithms for patients with a diagnosed or suspected COVID-19 infection, presenting with ST- and non-ST-segment elevation ACS are described. In addition, we address the need for re-organization of ACS networks, with redistribution of hub and spoke hospitals, as well as for in-hospital reorganization of emergency rooms and cardiac units, with examples coming from multiple European countries. Furthermore, we provide a guidance to reorganization of catheterization laboratories and, importantly, measures for protection of healthcare providers involved with invasive procedures.
Filiaciones:
Chieffo, A:
Osped San Raffaele, IRCCS, Intervent Cardiol Unit, Milan, Italy
Stefanini, GG:
IRCCS, Humanitas Clin & Res Hosp, Milan, Italy
Price, S:
Royal Brompton Hosp, London, England
Barbato, E:
Univ Federico II, Dept Adv Biomed Sci, Naples, Italy
Tarantini, G:
Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Intervent Cardiol Unit, Padua, Italy
Karam, N:
Hop Europeen Georges Pompidou, Dept Cardiol, Paris, France
Univ Paris, Paris, France
Moreno, R:
Hosp La Paz, Dept Cardiol, Madrid, Spain
IdiPaz, Madrid, Spain
Buchanan, GL:
North Cumbria Integrated Care NHS Fdn Trust, Dept Cardiol, Carlisle, Cumbria, England
Gilard, M:
Brest Univ Hosp, Serv Cardiol, Brest, France
Halvorsen, S:
Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway
Univ Oslo, Oslo, Norway
Huber, K:
Wilhelminen Hosp, Dept Med Cardiol & Intens Care Med 3, Vienna, Austria
Sigmund Freud Univ, Sch Med, Vienna, Austria
James, S:
Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden
Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
Neumann, FJ:
Univ Heart Ctr Freiburg, Div Cardiol & Angiol 2, Bad Krozingen, Germany
Mollmann, H:
St Johannes Hosp, Innere Med Klin 1, Dept Cardiol, Dortmund, Germany
Roffi, M:
Univ Hosp, Div Cardiol, Geneva, Switzerland
Tavazzi, G:
San Matteo Hosp, Fdn Policlin, Dept Clin Surg Diagnost & Pediat Sci, Unit Anaesthesia & Intens Care,IRCCS, Pavia, Italy
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Windecker, S:
Univ Hosp Bern, Swiss Cardiovasc Ctr, Dept Cardiol, Bern, Switzerland
Dudek, D:
Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland
Maria Cecilia Hosp GVM, Ravenna, Italy
Baumbach, A:
Queen Mary Univ London, William Harvey Res Inst, Ctr Cardiovasc Med & Devices, Charterhouse Sq, London EC1M 6BQ, England
Yale Univ, Sch Med, New Haven, CT USA
Green Submitted, Green Published, Bronze
|